A Phase II Trial to Assess the Effect of Cinacalcet Hydrochloride on PSA Levels in Patients With Biochemically Recurrent Prostate Cancer After Failed Definitive Local Therapy.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Sep 2017
At a glance
- Drugs Cinacalcet (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 31 Jan 2013 Planned end date changed from 1 Jan 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 17 Apr 2012 Planned end date changed from 1 Sep 2015 to 1 Jan 2013 as reported by ClinicalTrials.gov.